Terms: = Breast cancer AND MUC16, CA125, CA-125 AND Staging
19 results:
1. Could uterine conservation be an option in presumed early-stage epithelial ovarian cancer?
Benoit L; Pajot C; Koual M; Nguyen-Xuan HT; Bentivegna E; Bats AS; Azaïs H
Arch Gynecol Obstet; 2023 Sep; 308(3):953-960. PubMed ID: 37031304
[TBL] [Abstract] [Full Text] [Related]
2. Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of breast cancer and its Association With Pathological Features and Molecular Types.
Zou H; Liu SH; Yang R; Wu XJ; Cao YP; Huang HF
Clin Breast Cancer; 2022 Jun; 22(4):e526-e535. PubMed ID: 34963613
[TBL] [Abstract] [Full Text] [Related]
3. Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian cancer.
Li L; Chen F; Lin A; Wang D; Shi Y; Chen G
Comput Math Methods Med; 2021; 2021():4854282. PubMed ID: 34721658
[TBL] [Abstract] [Full Text] [Related]
4. Expression levels and clinical values of miR-92b-3p in breast cancer.
Du Y; Miao Z; Wang K; Lv Y; Qiu L; Guo L
World J Surg Oncol; 2021 Aug; 19(1):239. PubMed ID: 34380511
[TBL] [Abstract] [Full Text] [Related]
5. Postoperative expressions of TRACP5b and ca125 in patients with breast cancer and their values for monitoring bone metastasis.
Feng C; Zhan Y; Shao H; Wang Z; Zhu S
J BUON; 2020; 25(2):688-695. PubMed ID: 32521854
[TBL] [Abstract] [Full Text] [Related]
6. Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients.
Keup C; Benyaa K; Hauch S; Sprenger-Haussels M; Tewes M; Mach P; Bittner AK; Kimmig R; Hahn P; Kasimir-Bauer S
Cell Mol Life Sci; 2020 Feb; 77(3):497-509. PubMed ID: 31254045
[TBL] [Abstract] [Full Text] [Related]
7. [CA 125 assay in the extension assessment of newly diagnosed breast cancers: why and how?].
Laffont A; Goussot V; Berriolo-Riedinger A; Riedinger JM
Ann Biol Clin (Paris); 2018 Oct; 76(5):553-561. PubMed ID: 30154065
[TBL] [Abstract] [Full Text] [Related]
8. Expression and significance of ER, PR, VEGF, CA15-3, ca125 and CEA in judging the prognosis of breast cancer.
Zhang SJ; Hu Y; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
Asian Pac J Cancer Prev; 2013; 14(6):3937-40. PubMed ID: 23886210
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review.
Growdon WB; Rauh-Hain JJ; Cordon A; Garrett L; Schorge JO; Goodman A; Boruta DM; Horowitz NS; del Carmen MG
Int J Gynecol Cancer; 2012 Mar; 22(3):417-24. PubMed ID: 22237383
[TBL] [Abstract] [Full Text] [Related]
10. Kinetics of CEA and CA15-3 correlate with treatment response in patients undergoing chemotherapy for metastatic breast cancer (MBC).
Di Gioia D; Heinemann V; Nagel D; Untch M; Kahlert S; Bauerfeind I; Koehnke T; Stieber P
Tumour Biol; 2011 Aug; 32(4):777-85. PubMed ID: 21553235
[TBL] [Abstract] [Full Text] [Related]
11. breast cancer anti-estrogen resistance protein 1 (BCAR1/p130cas) in pulmonary disease tissue and serum.
Deng B; Huang W; Tan QY; Fan XQ; Jiang YG; Liu L; Zhong YY; Liang YG; Wang RW
Mol Diagn Ther; 2011 Feb; 15(1):31-40. PubMed ID: 21469768
[TBL] [Abstract] [Full Text] [Related]
12. Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: a case report and literature review.
Susini T; Olivieri S; Molino C; Castiglione F; Tavella K; Viligiardi R
J Womens Health (Larchmt); 2010 Jan; 19(1):169-74. PubMed ID: 20088673
[TBL] [Abstract] [Full Text] [Related]
13. A case of Meigs syndrome mimicking metastatic breast carcinoma.
Lanitis S; Sivakumar S; Behranwala K; Zacharakis E; Al Mufti R; Hadjiminas DJ
World J Surg Oncol; 2009 Jan; 7():10. PubMed ID: 19161612
[TBL] [Abstract] [Full Text] [Related]
14. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
[TBL] [Abstract] [Full Text] [Related]
15. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract] [Full Text] [Related]
16. CA 125 elevation in breast cancer: a case report and review of the literature.
Leonard GD; Low JA; Berman AW; Swain SM
Breast J; 2004; 10(2):146-9. PubMed ID: 15009043
[TBL] [Abstract] [Full Text] [Related]
17. Positron emission tomography scanning in gynecologic and breast cancers.
Zimny M; Siggelkow W
Curr Opin Obstet Gynecol; 2003 Feb; 15(1):69-75. PubMed ID: 12544505
[TBL] [Abstract] [Full Text] [Related]
18. [A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients)].
Fondrinier E; Guérin O; Lorimier G
Bull Cancer; 1997 Dec; 84(12):1101-7. PubMed ID: 9587361
[TBL] [Abstract] [Full Text] [Related]
19. Preoperative and longitudinal serum levels of CA 125 and CA 15.3 in patients with breast cancer.
Omar YT; Behbehani AE; al-Naqeeb N; Motawy MM; Foudeh MO; Awwad AH; Nasralla MY; Szymendera JJ
Int J Biol Markers; 1989; 4(2):81-6. PubMed ID: 2768892
[TBL] [Abstract] [Full Text] [Related]
